{
  "id": 552,
  "text": "3 0 2$ ).No significant difference with respect to 5-year DFS was also reported ( $8 3 .1 \\%$ versus $7 7 .4 \\% ,$ respectively, $\\mathrm { p } = 0 .2 2 8 \\mathrm { ^ { \\prime } }$ ).The incidence rates of late grade 3 genitourinary adverse reactions were significantly higher in the primary surgery group ( $0 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 3 0 2$ ).No significant difference with respect to 5-year DFS was also reported ( $8 3 .1 \\%$ versus $7 7 .4 \\% ,$ respectively, $\\mathrm { p } = 0 .2 2 8 \\mathrm { ^ { \\prime } }$ ).The incidence rates of late grade 3 genitourinary adverse reactions were significantly higher in the primary surgery group ( $0 .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "对于接受初步手术的患者和接受放疗的患者，5年无病生存率没有显著差异的原因可能与以下几个方面有关：\n\n1. **疾病控制能力相近**：初步手术和放疗作为治疗策略，都能够有效地控制疾病扩散，并降低复发概率。因此，两者在长期无病生存率方面可能表现出相近的效果。\n\n2. **治疗方案选择的个体化**：针对不同患者，治疗方案的选择依据多个因素（如肿瘤分期、患者健康状况等），这可能也导致两组数据在总体比较上没有显著差异。\n\n3. **统计差异的可能性**：从数据中可以看出，初步手术组的5年无病生存率为83.1%，而放疗组为77.4%。尽管数值有一定差距，但统计学分析未达到显著性水平（p值=0.228），表明这种差异可能属于随机变异。\n\n需要注意的是，尽管两种方法在无病生存率上没有显著差异，但不同治疗策略可能带来不同的并发症风险。比如，初步手术的患者更容易出现晚期3级泌尿生殖系统不良反应，因此治疗方案的选择应综合考虑疗效与安全性。",
  "query": "对于接受初步手术的患者，为什么5年无病生存率与接受放疗的患者没有显著差异？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 对于接受初步手术的患者，为什么5年无病生存率与接受放疗的患者没有显著差异？\n\n<reference text>: 3 0 2$ ).No significant difference with respect to 5-year DFS was also reported ( $8 3 .1 \\%$ versus $7 7 .4 \\% ,$ respectively, $\\mathrm { p } = 0 .2 2 8 \\mathrm { ^ { \\prime } }$ ).The incidence rates of late grade 3 genitourinary adverse reactions were significantly higher in the primary surgery group ( $0 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "对于接受初步手术的患者和接受放疗的患者，5年无病生存率没有显著差异的原因可能与以下几个方面有关：\n\n1. **疾病控制能力相近**：初步手术和放疗作为治疗策略，都能够有效地控制疾病扩散，并降低复发概率。因此，两者在长期无病生存率方面可能表现出相近的效果。\n\n2. **治疗方案选择的个体化**：针对不同患者，治疗方案的选择依据多个因素（如肿瘤分期、患者健康状况等），这可能也导致两组数据在总体比较上没有显著差异。\n\n3. **统计差异的可能性**：从数据中可以看出，初步手术组的5年无病生存率为83.1%，而放疗组为77.4%。尽管数值有一定差距，但统计学分析未达到显著性水平（p值=0.228），表明这种差异可能属于随机变异。\n\n需要注意的是，尽管两种方法在无病生存率上没有显著差异，但不同治疗策略可能带来不同的并发症风险。比如，初步手术的患者更容易出现晚期3级泌尿生殖系统不良反应，因此治疗方案的选择应综合考虑疗效与安全性。"
}